NWBO Northwest Biotherapeutics, Inc.

$0.17

Northwest Biotherapeutics, Inc. (NWBO) Institutional Ownership

What the institutions did with NWBO last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.

Managers compared
7
filed both this quarter and last
Managers holding
7
+0 on the quarter
Buyers
1
0 opened new
Sellers
0
0 sold out entirely
Buyer share
100.0%
of managers who traded it
Breadth
+100.0
net buyers, as a share of those trading

Only 7 managers reported a position this quarter, so the percentages above describe a very small sample.

Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.

Sign in or subscribe

Ownership map

Each block is one manager, sized by shares held and colored by how much they moved the position last quarter. Green added, red cut, grey stood pat.

Cut Unchanged Added Color saturates at ±50%.

Largest holders

Manager Shares % of reported
COMPASS FINANCIAL MANAGEMENT LLC 1.2M 54.7%
KELLEHER FINANCIAL ADVISORS 800.0K 36.0%
VSM Wealth Advisory, LLC 80.6K 3.6%
Opus Capital Group, LLC 60.2K 2.7%
Ethos Financial Group, LLC 39.1K 1.8%
Williams Jones Wealth Management, LLC. 25.0K 1.1%
Coston, McIsaac & Partners 1.0K 0.0%
HANTZ FINANCIAL SERVICES, INC. 250 0.0%

Largest changes

Manager Action Previous Current Change
KELLEHER FINANCIAL ADVISORS Increased 200.0K 800.0K +600.0K

13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.